Literature DB >> 2638240

Visual function in multiple sclerosis.

B Ashworth1, P A Aspinall, J D Mitchell.   

Abstract

126 patients with multiple sclerosis and normal visual acuity were submitted to a battery of tests of visual function. The investigation included visual evoked potential, contrast sensitivity by three methods, and a segment of the Farnsworth-Munsell 100 Hue test. 22 of the patients gave a history of unilateral acute optic neuritis and in these the abnormalities were greater in degree. Contrast sensitivity emerged as the most useful test and was abnormal in 92.2% of eyes. Visual evoked potential was delayed in 35.6% and colour vision was abnormal in less than a third. In general, contrast sensitivity was depressed at all frequencies and most of the abnormalities could be identified by testing at a single frequency of 4 cycles/degree.

Entities:  

Mesh:

Year:  1989        PMID: 2638240     DOI: 10.1007/bf00155090

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  29 in total

1.  Estimation of visual function after optic neuritis: a comparison of clinical tests.

Authors:  E A Sanders; A C Volkers; J C van der Poel; G H van Lith
Journal:  Br J Ophthalmol       Date:  1986-12       Impact factor: 4.638

2.  Visual function and pattern visual evoked response in optic neuritis.

Authors:  E A Sanders; A C Volkers; J C van der Poel; G H van Lith
Journal:  Br J Ophthalmol       Date:  1987-08       Impact factor: 4.638

3.  Visual evoked response in diagnosis of multiple sclerosis.

Authors:  A M Halliday; W I McDonald; J Mushin
Journal:  Br Med J       Date:  1973-12-15

4.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

5.  Contrast sensitivity measurements in acute and resolved optic neuritis.

Authors:  R W Beck; M C Ruchman; P J Savino; N J Schatz
Journal:  Br J Ophthalmol       Date:  1984-10       Impact factor: 4.638

6.  Orientation-specific losses of contrast sensitivity in multiple sclerosis.

Authors:  D Regan; J A Whitlock; T J Murray; K I Beverley
Journal:  Invest Ophthalmol Vis Sci       Date:  1980-03       Impact factor: 4.799

7.  Contrast sensitivity, visual acuity and the discrimination of Snellen letters in multiple sclerosis.

Authors:  D Regan; J Raymond; A P Ginsburg; T J Murray
Journal:  Brain       Date:  1981-06       Impact factor: 13.501

8.  The rapid assessment of visual dysfunction in multiple sclerosis.

Authors:  S Della Sala; G Comi; V Martinelli; L Somazzi; A J Wilkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-07       Impact factor: 10.154

9.  Contrast sensitivity loss in multiple sclerosis. Selectivity by eye, orientation, and spatial frequency measured with the evoked potential.

Authors:  M J Kupersmith; W H Seiple; J I Nelson; R E Carr
Journal:  Invest Ophthalmol Vis Sci       Date:  1984-06       Impact factor: 4.799

10.  Screening for antimalarial maculopathy in rheumatology clinics.

Authors:  B W Fleck; A L Bell; J D Mitchell; B J Thomson; N P Hurst; G Nuki
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-21
View more
  8 in total

1.  Genetic influence on contrast sensitivity in middle-aged male twins.

Authors:  Alice Cronin-Golomb; Matthew S Panizzon; Michael J Lyons; Carol E Franz; Michael D Grant; Kristen C Jacobson; Seth A Eisen; Thomas M Laudate; William S Kremen
Journal:  Vision Res       Date:  2007-06-29       Impact factor: 1.886

Review 2.  Using the Anterior Visual System to Assess Neuroprotection and Remyelination in Multiple Sclerosis Trials.

Authors:  Elizabeth Silbermann; Lindsey Wooliscroft; Dennis Bourdette
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-19       Impact factor: 5.081

Review 3.  Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection.

Authors:  Reiko E Sakai; Daniel J Feller; Kristin M Galetta; Steven L Galetta; Laura J Balcer
Journal:  J Neuroophthalmol       Date:  2011-12       Impact factor: 3.042

4.  Effect of 4-aminopyridine on vision in multiple sclerosis patients with optic neuropathy.

Authors:  Lindsay Horton; Amy Conger; Darrel Conger; Gina Remington; Teresa Frohman; Elliot Frohman; Benjamin Greenberg
Journal:  Neurology       Date:  2013-04-24       Impact factor: 9.910

5.  Influence of multiple sclerosis, age and degree of disability, in the position of the contrast sensitivity curve peak.

Authors:  A F Nunes; P M L Monteiro; M Vaz Pato
Journal:  Indian J Ophthalmol       Date:  2014-02       Impact factor: 1.848

Review 6.  Vision and vision-related outcome measures in multiple sclerosis.

Authors:  Laura J Balcer; David H Miller; Stephen C Reingold; Jeffrey A Cohen
Journal:  Brain       Date:  2014-11-28       Impact factor: 13.501

7.  Different Impacts of Luminosity on Contrast Vision in Eyes with Transparent Optic Media and with Cataract Simulation.

Authors:  Adrian Smedowski; Karolina Mikus-Zagorska; Agnieszka Jakubowska; Anna Piotrowska-Gwozdz; Agnieszka Piotrowska-Seweryn; Patrycja Orchel; Dorota Pojda-Wilczek
Journal:  Med Princ Pract       Date:  2015-06-26       Impact factor: 1.927

8.  Functional Evaluation of the Visual Pathway in Patients with Multiple Sclerosis Using a Multifunction Stimulator Monitor.

Authors:  M Satue; L Jarauta; J Obis; M Cipres; M J Rodrigo; C Almarcegui; I Dolz; J R Ara; J Martin; L E Pablo; E Garcia-Martin
Journal:  J Ophthalmol       Date:  2019-09-18       Impact factor: 1.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.